subgroup of
benefit)
→
ReceivesAction
→
observed through continued use
| Typicality: | 0.233 |
| Saliency: | 0.166 |
| like most supplements | 4 | other |
| maximum benefit → be observed through → continued use | 4 |
| negative | neutral | positive |
| 0.005 | 0.213 | 0.782 |
| Raw frequency | 4 |
| Normalized frequency | 0.166 |
| Modifier score | 0.500 |
| Perplexity | 256.913 |